Fig. 2From: Neohesperidin promotes the osteogenic differentiation of bone mesenchymal stem cells by activating the Wnt/β-catenin signaling pathwayA NEO dose-dependently increased the osteogenesis-related genes. a Relative expression of RUNX2 expression in control and NEO treatment groups. b Relative expression of BMP2 expression in control and NEO treatment groups. c Relative expression of osteocalcin expression in control and NEO treatment groups. d Relative expression of β-catenin expression in control and NEO treatment groupsBack to article page